Kevin O’Leary says the ‘real opportunity’ for Bitcoin will come from this overlooked group of investors — but he’s still a big fan of blue chip dividend stocks


Pfizer-BioNTech’s COVID-19 Vaccine Shows 100% Effectiveness In Long Term Analysis In Adolescents

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 Vaccine in individuals 12 through 15 years of age. The updated findings from the Phase 3 trial show that a two-dose series of the Vaccine (30-µg per dose) was 100% effective against COVID-19, measured seven days through over four months after the second dose. Data from almost 2,230 participants showed that 30 cases of COVID-19 were reported

Leave a Reply

Your email address will not be published. Required fields are marked *